Sort
53,477 grants matching “addiction”
Autophagic regulation of cocaine abuse
$530,420Congcong He · Northwestern University At Chicago · R01 · FY2025 · DA
Autophagic regulation of cocaine abuse
$530,420Congcong He · Northwestern University At Chicago · R01 · FY2024 · DA
Trans-synaptic signaling complex in amygdala pain mechanisms
$530,374Shashank Manohar Dravid · Creighton University · R01 · FY2022 · NS
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIA
$530,372Jennifer W Tidey · University Of Pittsburgh At Pittsburgh · U54 · FY2014 · DA
Imaging Core
$530,336Richard E Carson · University Of Pennsylvania · P30 · FY2019 · DA
Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BC
$530,331Julio Sergio Gonzalez Montaner · University Of British Columbia · R01 · FY2014 · DA
Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BC
$530,331Julio Sergio Gonzalez Montaner · University Of British Columbia · R01 · FY2013 · DA
Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BC
$530,331Julio Sergio Gonzalez Montaner · University Of British Columbia · R01 · FY2017 · DA
Valproate Efficacy in Cocaine-Bipolar Comorbidity
$530,310Ihsan M Salloum · University Of Miami School Of Medicine · R01 · FY2011 · DA
Lipid biosignatures of drug addiction
$530,178Daniele Piomelli · University Of California-Irvine · RC2 · FY2010 · DA
Hispanic Clinical and Translational Research Education and Career Development(HCT
$530,123Estela S Estape · University Of Puerto Rico Med Sciences · R25 · FY2012 · MD
Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses
$530,118Mary E McCaul · Johns Hopkins University · R01 · FY2010 · DA
Cognitive control and cocaine dependence: thalamic noradrenergic processes
$530,096Chiang-Shan Ray Li · Yale University · R01 · FY2017 · DA
NBER Roybal Center for Behavior Change in Health
$530,080Joseph J Doyle · National Bureau Of Economic Research · P30 · FY2023 · AG
The National Drug Abuse Treatment Clinical Trials Network (U10)
$530,000Roger D. Weiss · Mclean Hospital · U10 · FY2010 · DA
Quetiapine for the treatment of Type A and Type B alcoholism
$529,995Kyle Matthew Kampman · University Of Pennsylvania · R01 · FY2009 · AA
Candidate Medications for Cannabis Addiction: FAAH Inhibitors
$529,932Jack Bergman · Mclean Hospital · R01 · FY2013 · DA
Maternal Opioid Treatment: Human Experimental Research
$529,918Vanderbilt University · R01 · FY2005 · DA
A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders
$529,915Kyle Matthew Kampman · University Of Pennsylvania · UG1 · FY2020 · DA
Use-Dependent Adjustments to Dopamine Reception in Motivational Control
$529,878Michael A Crickmore · Boston Children'S Hospital · R01 · FY2025 · NS
Continuity of the Limbic Circuit Through the Basal Ganglia
$529,830Suzanne N Haber · University Of Rochester · R01 · FY2016 · MH
The Role of Opioid Adherence Profiles in Cancer Pain Self-Management and Outcomes
$529,793Salimah H. Meghani · University Of Pennsylvania · R01 · FY2022 · NR
Aerobic Exercise to Improve Outcomes of Treatment for Methamphetamine Dependence
$529,766Richard A Rawson · University Of California Los Angeles · R01 · FY2010 · DA
A Novel Compound for Alcoholism Treatment: a Translational Strategy
$529,761Fatemeh Akhlaghi · University Of Rhode Island · UH3 · FY2016 · TR
Basic Science Training Program in Drug Abuse Research
$529,748David W Self · Ut Southwestern Medical Center · T32 · FY2016 · DA